company

IR CLINICAL CANCER DIAGNOSTICS AS

0570 OSLO

Return on Equity
6,6 %
Current Ratio
1,5
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue634 000
Net Income33 000
Total Assets861 000
Total Equity500 000
Income (NOK)2022
Revenue634 000
Expenditure601 000
Operating Profit33 000
Financial Income0
Financial Costs0
Financial Balance0
Earnings Before Tax33 000
Tax0
Net Income33 000
Balance (NOK)2022
Total Fixed Assets320 000
Total Current Assets541 000
Total Assets861 000
Total Retained Equity0
Total Equity500 000
Total Long-Term Debt0
Total Current Debt361 000
Total Equity and Debt861 000
Cash flow (NOK)2022
Sales Income634 000
Other Income0
Revenue634 000
Cost of Goods Sold166 000
Salary Costs300 000
Depreciation0
Impairment0
Expenditure601 000
Operating Profit33 000
Financial Income0
Financial Costs0
Financial Balance0
Dividends0
Net Income33 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets320 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets320 000
Stock0
Total Investments0
Cash, Bank541 000
Total Current Assets541 000
Total Assets861 000
Total Equity500 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors0
Unpaid Taxes0
Dividends0
Other Current Debt361 000
Total Current Debt361 000
Total Equity and Debt861 000
Financial indicators2022
Return on Equity6,6 %
Debt-to-Equity Ratio0
Operating Profit Margin5,21 %
Current Ratio1,5
Quick Ratio1,5
Equity Ratio0,58
Gross Profit Margin73,82 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English